MHRA clarifies printing, Braille requirements for drug packs
This article was originally published in SRA
Executive Summary
The UK’s Medicines and Healthcare products Regulatory Agency has clarified some regulatory issues relating to the Braille and patient leaflet requirements in EU medicines legislation as they apply to drug packaging or printing of patient information leaflets.